PDKHX Performance — PGIM Target Date 2055 Fund, Class R5
Data updated: 2026-10-13
PDKHX returned +11.96% year to date and +22.55% over one year to Jul 2026. Annualised returns are +16.25% over 3 years and +9.67% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $157, against $146 for the category, and to $123 over one year, against $116. Volatility over the past three years was 11.67% a year. In the 12 months to Jul 2026 the fund lost a net $58K, and assets reached $11.80M.
PDKHX Growth of $100
What $100 invested in PGIM Target Date 2055 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | PDKHX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $123 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $157 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $159 | $142 |
| Since data start (Aug 2019 – Jul 2026) | $219 | $186 |
PDKHX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.96% |
| 1 year | +22.55% |
| 3 years (annualised) | +16.25% |
| 5 years (annualised) | +9.67% |
PDKHX Annual Returns
Calendar-year total returns of PGIM Target Date 2055 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +11.96% |
| 2025 | +19.52% |
| 2024 | +13.49% |
| 2023 | +18.38% |
| 2022 | −15.33% |
| 2021 | +19.49% |
| 2020 | +11.57% |
| 2019 (Aug–Dec) | +7.97% |
PDKHX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.3% | +2.4% | −6.4% | +8.9% | +3.8% | +0.8% | −0.7% | — | — | — | — | — |
| 2025 | +3.1% | −0.4% | −3.1% | +0.2% | +4.9% | +4.0% | +0.3% | +3.2% | +2.8% | +1.5% | +0.7% | +0.9% |
| 2024 | −0.4% | +3.9% | +3.1% | −3.6% | +4.2% | +1.0% | +2.3% | +2.3% | +2.0% | −2.5% | +3.6% | −3.0% |
| 2023 | +7.1% | −3.0% | +1.6% | +0.9% | −1.7% | +5.7% | +3.4% | −2.4% | −4.0% | −3.1% | +8.2% | +5.3% |
| 2022 | −3.8% | −1.7% | +1.6% | −6.8% | +0.8% | −8.7% | +7.1% | −3.9% | −9.4% | +6.3% | +8.0% | −4.2% |
| 2021 | +0.2% | +3.1% | +3.4% | +4.1% | +1.6% | +0.6% | +0.9% | +1.9% | −3.8% | +4.5% | −2.6% | +4.4% |
| 2020 | −1.8% | −7.7% | −14.8% | +10.2% | +4.9% | +2.8% | +4.4% | +4.8% | −2.9% | −1.6% | +11.0% | +4.8% |
| 2019 | — | — | — | — | — | — | — | −2.2% | +2.3% | +2.3% | +2.4% | +3.1% |
PDKHX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 11.67%
- 3-year Sharpe ratio: 1.01 (vs 4.5% risk-free rate)
- Best month: +8.90% (Apr 2026)
- Worst month: −6.42% (Mar 2026)
PDKHX Fund Flows
Monthly money in and out of PGIM Target Date 2055 Fund, from SEC Form N-PORT.
- 12-month net flow: −$58K
- 12-month gross sales (incl. reinvestments): $5.5M
- Sales ÷ redemptions: 0.99×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $229K | $185K | $44K |
| Jun 2026 | $158K | $139K | $19K |
| May 2026 | $152K | $1.3M | −$1.1M |
| Apr 2026 | $133K | $409K | −$276K |
| Mar 2026 | $396K | $1.4M | −$993K |
| Feb 2026 | $181K | $112K | $70K |
| Jan 2026 | $261K | $1.2M | −$920K |
| Dec 2025 | $2.5M | $282K | $2.2M |
| Nov 2025 | $169K | $203K | −$34K |
| Oct 2025 | $1.0M | $50K | $965K |
| Sep 2025 | $138K | $112K | $26K |
| Aug 2025 | $164K | $186K | −$22K |
PDKHX Assets Under Management
Net assets of PGIM Target Date 2055 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $11.80M |
| 2026-04-30 | $12.45M |
| 2026-01-30 | $13.15M |
| 2025-10-31 | $11.81M |
| 2025-07-31 | $10.04M |
| 2025-04-30 | $9.16M |
| 2025-01-31 | $9.37M |
| 2024-10-31 | $8.66M |
| 2024-07-31 | $8.29M |
| 2024-04-30 | $7.12M |
| 2024-01-31 | $6.20M |
| 2023-10-31 | $8.44M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.